Home
Learn More
Release Features
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 9, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
 
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for May 22, 2008 Subscribe to this News Feed      
 

American Company to Offer Dog Cloning Service at International Public Auction

BioArts International to Clone the Dogs of Five Winning Bidders in June Auction.

Mill Valley, CA (Vocus/PRWEB ) May 22, 2008 -- BioArts International (BioArts), today announced that it will sell five dog cloning service slots to the general public via a worldwide, online auction to be held June 18th.

"We are thrilled to announce the Best Friends Again program," said CEO Lou Hawthorne. "This auction will give five very lucky people the ability to clone their family dogs. Given how challenging it is to clone dogs, this is a very rare and special offer."

This auction will give five very lucky people the ability to clone their family dogs. Given how challenging it is to clone dogs, this is a very rare and special offer.
The Best Friends Again website showcases three perfect clones of Hawthorne's beloved family dog "Missy", who died in 2002. Missy has been the subject of extensive cloning research since the "Missyplicity Project" began in 1997. "I can't decide which is more exciting: finally having three clones of Missy or being able to offer this amazing service to others." said Hawthorne.

BioArts has been granted the sole, worldwide license for the cloning of dogs, cats and endangered species. The license was granted by Start Licensing, Inc. and applies to the somatic cell nuclear transfer (SCNT) cloning patents developed at the Roslin Institute for the cloning of Dolly the sheep.

BioArts International is a new biotech startup focused on unique, untapped markets in the global companion animal, premium livestock and human genomics industries. The Best Friends Again program is a partnership between BioArts and the Sooam Biotech Research Foundation in South Korea, home to the best and most experienced dog cloning team in the world.

More information about the Best Friends Again program and the June 18th auction is available at www.bestfriendsagain.com. More information about BioArts is available at www.bioarts.com.

###

Post Comment:
Trackback URL: http://ca.prweb.com/pingpr.php/Q3Jhcy1Ib3JyLVByb2YtWmV0YS1DcmFzLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web



OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Kiley Russell
Bioarts
(415) 227-9700 *107
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright